Indication
Acute Graft-Versus-Host Disease
2 clinical trials
2 products
Product
JaktinibClinical trial
A Phase 2 ,Safety and Efficacy Study of Jaktinib Hydrochloride Tablets for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.Status: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Randomized Phase 2 Study to Examine the Impact of Gut Decontamination on Intestinal Microbiome Composition in Pediatric Allogeneic Hematopoietic Stem Cell Transplant PatientsStatus: Completed, Estimated PCD: 2021-04-15
Product
Vancomycin + Polymyxin B